A Follow-up Study With Children Who Participated in the TEMPO Study in Their First Year of Life
NCT05449756 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 705
Last updated 2023-12-11
Summary
This is a follow-up study of a randomised clinical trial, called TEMPO (a double-blind randomized clinical trial investigating infant formula and human breast milk consumption), in which infants participated in their first year of life. The investigators like to know if these children develop allergies or infections in childhood and whether their feeding pattern in infancy plays a role.
Conditions
- Allergy
- Infections
Interventions
- OTHER
-
Self-administered questionnaires
Three-monthly self-administered digital questionnaires (accessed on smartphone, tablet or computer)
Sponsors & Collaborators
-
Nutricia Research
lead INDUSTRY
Eligibility
- Min Age
- 3 Years
- Max Age
- 10 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-05-30
- Primary Completion
- 2029-03-31
- Completion
- 2029-03-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Effect of Infant Formula on Energy Balance
NCT01700205 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Tolerance of a Follow-On Formula Fed to Children From 12-48 Months of Age in Salvador, Bahia, Brazil
NCT01431469 ·Status: COMPLETED ·Phase: NA
-
Effect of Oral Colostrum Applications Every 2 Hours and 4 Hours In Order to Achieve Trophic Feeding in Preterm Infants
NCT06379178 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study to Investigate the Effect of a Partially Hydrolysed Infant Formula With Added Synbiotics on the Development of Allergic Manifestations in Infants at High Risk of Developing Allergy
NCT03062995 ·Status: WITHDRAWN ·Phase: PHASE3
-
Predictors of Persistent Peanut Allergy at Age 5 Years
NCT02497261 ·Status: ENROLLING_BY_INVITATION
-
Effectiveness and Safety of Fast Enteral Feeding in Preterm Infants Between 1000 and 2000 Grams of Birth Weight
NCT02998489 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Effects of a New Formula on the Growth, Safety and Tolerance of Infants With Growth Failure
NCT03563391 ·Status: COMPLETED ·Phase: NA
-
A Follow-up Study to Investigate the Effects of a New Infant Formula on Growth and Body Composition
NCT02594683 ·Status: COMPLETED
-
Infant Formula in Infants and Children With Cow's Milk Allergy
NCT06456541 ·Status: RECRUITING ·Phase: NA
-
Study on The Oral Immune Tolerance of CMPA Infants Using Amino Acid Formula
NCT03769051 ·Status: COMPLETED
-
Follow up of Long Term Neurodevelopmental Impact of the Type of Feeding During the First Year of Life at 10 Years Old
NCT06917625 ·Status: ACTIVE_NOT_RECRUITING
-
Effects of Infant Formula Composition on Infant Feeding Behaviors
NCT00957892 ·Status: COMPLETED
-
Study on the Efficacy and Tolerance of a New Anti-regurgitation Infant Formula (STELLAR)
NCT04358146 ·Status: RECRUITING ·Phase: NA
-
Oral Tolerance in Cow's Milk Allergy in the Infant
NCT00298376 ·Status: UNKNOWN
-
Remote Food Photography Method in Infants
NCT01762631 ·Status: COMPLETED
-
Formula for Children With Cow's Milk Allergy
NCT02317952 ·Status: COMPLETED ·Phase: NA
-
Assessment of Feeding Tolerance in Infants Fed Cow Milk Formula
NCT00666120 ·Status: COMPLETED ·Phase: NA
-
Tube Feeding Tolerance After Switch to Peptide Based Formula in Children With Developmental Delay
NCT02912065 ·Status: COMPLETED
-
Growth and Tolerance of Infants Fed Formula for 16 Weeks
NCT03487094 ·Status: COMPLETED ·Phase: NA
-
Preterm Infants Fed a Human Milk Fortifier
NCT05551975 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Fact-based Nutrition for Infants and Lactating Mothers
NCT05646940 ·Status: COMPLETED
-
Tolerance of Healthy Infants Fed Infant Formulas
NCT02401217 ·Status: COMPLETED ·Phase: NA
-
Prevention of Allergic Diseases in Infants
NCT03489733 ·Status: COMPLETED ·Phase: NA
-
Assessment of Gastrointestinal Discomfort and Infections in Healthy Term Infants
NCT06744699 ·Status: ACTIVE_NOT_RECRUITING
-
Growth, Safety and Tolerance of a Hydrolyzed Protein Infant Formula
NCT05618704 ·Status: COMPLETED ·Phase: NA